Antihypertensive treatment for kidney transplant recipients-Reference-Cited by-同舟云学术

Antihypertensive treatment for kidney transplant recipients

Published:2024-07-31 Issue:8 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Natale Patrizia¹²³,Mooi Pamela KL⁴,Green Suetonia C⁵,Cross Nicholas B⁴⁶,Cooper Tess E⁷,Webster Angela C¹⁷⁸⁹,Masson Philip¹⁰,Craig Jonathan C¹¹¹²,Strippoli Giovanni FM³¹¹

Affiliation:

1. Sydney School of Public Health; The University of Sydney; Sydney Australia

2. Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences; University of Foggia; Foggia Italy

3. Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J); University of Bari Aldo Moro; Bari Italy

4. Department of Nephrology; Christchurch Hospital, Te Whatu Ora Waitaha Canterbury; Christchurch New Zealand

5. Department of Medicine; University of Otago Christchurch; Christchurch New Zealand

6. New Zealand Clinical Research, 3/264 Antigua St; Christchurch New Zealand

7. NHMRC Clinical Trials Centre, Faculty of Medicine and Health; The University of Sydney; Sydney Australia

8. Westmead Applied Research Centre; The University of Sydney at Westmead; Westmead Australia

9. Department of Transplant and Renal Medicine; Westmead Hospital; Westmead Australia

10. Department of Renal Medicine; Royal Free London NHS Foundation Trust; London UK

11. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

12. College of Medicine and Public Health; Flinders University; Adelaide Australia

Publisher

Wiley

Reference393 articles.

1. Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the Angiotensin II Blockade in Chronic Allograft Nephropathy Trial;Hart;Transplantation,2014

2. Elevated uric acid is not associated with a faster GFR decline in renal transplant recipients [abstract no: 804];Ibrahim;American Journal of Transplantation,2011

3. Angiotensin II blockade in kidney transplant recipients;Ibrahim;Journal of the American Society of Nephrology,2013

4. A randomized 5-year trial of angiotensin II blockade vs. placebo in kidney transplant recipients [abstract no: SA-PO1122];Ibrahim;Journal of the American Society of Nephrology,2012

5. The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure [Erratum in: Kidney Int. 2015 Jan;87(1):243 Note: Najafian, Behzad [Added]; PMID: 25549130];Issa;Kidney International,2014